International Journal of Critical Illness and Injury Science

EDITORIAL
Year
: 2021  |  Volume : 11  |  Issue : 3  |  Page : 109--111

What's new in critical illness and injury science? An evidence-based analysis of the impact of Janus Kinase inhibitors on 28-day mortality in patients admitted with COVID-19


Andrew C Miller1, Yannick A D'Silva2 
1 Department of Emergency Medicine, Alton Memorial Hospital, Alton, IL, USA
2 Department of Internal Medicine, Rhode Island Hospital and Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA

Correspondence Address:
Dr. Andrew C Miller
Department of Emergency Medicine, Alton Memorial Hospital, One Memorial Drive, Alton, IL 62002
USA




How to cite this article:
Miller AC, D'Silva YA. What's new in critical illness and injury science? An evidence-based analysis of the impact of Janus Kinase inhibitors on 28-day mortality in patients admitted with COVID-19.Int J Crit Illn Inj Sci 2021;11:109-111


How to cite this URL:
Miller AC, D'Silva YA. What's new in critical illness and injury science? An evidence-based analysis of the impact of Janus Kinase inhibitors on 28-day mortality in patients admitted with COVID-19. Int J Crit Illn Inj Sci [serial online] 2021 [cited 2021 Dec 5 ];11:109-111
Available from: https://www.ijciis.org/article.asp?issn=2229-5151;year=2021;volume=11;issue=3;spage=109;epage=111;aulast=Miller;type=0